ESC Premium Access

Prognostic impact of SYNTAX Score in patients with myocardial infarction with multivessel coronary artery disease and cardiogenic shock: insight from the CULPRIT-SHOCK Trial

Congress Presentation

About the speaker

Doctor Paul Guedeney

Pitie Salpetriere APHP University Hospital, Paris (France)
0 follower

4 more presentations in this session

State of the Art - Ten years after syntax: a surgeon's perspective

Speaker: Professor M. Borger (Leipzig, DE)

Thumbnail

FFR guided acute complete revascularization versus culprit lesion only treatment in patients presenting with STEMI and multi vessel disease; final 3-year outcome data from Compare-Acute trial

Speaker: Doctor P. Smits (Rotterdam, NL)

Thumbnail

Coronary artery bypass grafting vs. FFR-guided PCI in diabetic patients with multivessel disease

Speaker: Doctor G. Di Gioia (Mercogliano, IT)

Thumbnail

Percutaneous coronary intervention in 2030: overcoming current PCI limitations

Speaker: Doctor A. Colombo (Milan, IT)

Thumbnail

Access the full session

Advances in revascularisation strategies in patients with multivessel disease

Speakers: Doctor P. Guedeney, Professor M. Borger, Doctor P. Smits, Doctor G. Di Gioia, Doctor A. Colombo
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb